{"hands_on_practices": [{"introduction": "The complex process of amyloid formation can be broken down into elementary kinetic steps. This first exercise focuses on the elongation phase, where monomers add to the ends of existing fibrils. By applying the principles of mass-action kinetics to this reversible process, you will derive a fundamental property of aggregation: the critical concentration, which dictates the direction of fibril growth [@problem_id:2591843].", "problem": "A single protofilament of an amyloid fibril elongates by the reversible addition of monomeric protein to its exposed end. Model the terminal step as the elementary reaction $F_{n} + M \\rightleftharpoons F_{n+1}$, where $F_{n}$ is the fibril with $n$ subunits at the end, $M$ is a free monomer, and $F_{n+1}$ is the fibril after adding one monomer at that end. Assume dilute solution so that activities equal concentrations and mass-action kinetics apply. The end-specific association is second order with rate constant $k_{+}$, and the end-specific dissociation is first order with rate constant $k_{-}$. Define the critical monomer concentration $c^{*}$ as the concentration at which there is no net elongation of the fibril end.\n\nUsing only mass-action kinetics and the definition of $c^{*}$, derive an expression for the net elongation velocity per fibril end, measured in monomer units per time, as a function of the monomer concentration $m$. Then evaluate this velocity for the following parameter values: $k_{+} = 3.2 \\times 10^{5}\\ \\mathrm{M^{-1}\\ s^{-1}}$, $k_{-} = 0.80\\ \\mathrm{s^{-1}}$, and $m = 7.5\\ \\mu\\mathrm{M}$. Express the final velocity in $\\mathrm{s^{-1}}$ (monomers per second per fibril end) and round your answer to three significant figures.", "solution": "We begin by conducting a rigorous validation of the problem statement.\n\nThe givens extracted from the statement are as follows:\n- The elementary reaction for fibril elongation is $F_{n} + M \\rightleftharpoons F_{n+1}$.\n- $F_{n}$ represents a fibril with $n$ subunits.\n- $M$ represents a free monomer, with concentration denoted as $m$.\n- The forward reaction (association) is second order with rate constant $k_{+}$.\n- The reverse reaction (dissociation) is first order with rate constant $k_{-}$.\n- It is assumed that activities are equal to concentrations.\n- The critical monomer concentration, $c^{*}$, is defined as the concentration $m$ at which net elongation is zero.\n- The specific parameter values for evaluation are: $k_{+} = 3.2 \\times 10^{5}\\ \\mathrm{M^{-1}\\ s^{-1}}$, $k_{-} = 0.80\\ \\mathrm{s^{-1}}$, and $m = 7.5\\ \\mu\\mathrm{M}$.\n- The final velocity is to be expressed in units of $\\mathrm{s^{-1}}$ and rounded to three significant figures.\n\nThe problem is deemed valid. It is scientifically grounded, describing a standard and well-accepted kinetic model of amyloid fibril polymerization. The problem is well-posed, with all necessary definitions, assumptions, and parameters provided for a unique solution. The language is objective and unambiguous. The provided constants and concentrations are physically plausible, and the units are consistent. There are no contradictions or logical flaws.\n\nWe proceed with the derivation and solution.\n\nThe net elongation velocity per fibril end, which we shall denote as $v$, is the rate of monomer association minus the rate of monomer dissociation. We use the principles of mass-action kinetics.\n\nThe rate of the forward reaction (association) for a single fibril end, $v_{+}$, is a second-order process. It is proportional to the concentration of free monomer, $m$.\n$$v_{+} = k_{+} m$$\nThe units are $(\\mathrm{M^{-1}\\ s^{-1}}) \\times (\\mathrm{M}) = \\mathrm{s^{-1}}$, which correspond to monomers per second per fibril end.\n\nThe rate of the reverse reaction (dissociation) for a single fibril end, $v_{-}$, is a first-order process that does not depend on the monomer concentration.\n$$v_{-} = k_{-}$$\nThe units are $\\mathrm{s^{-1}}$, again corresponding to monomers per second per fibril end.\n\nThe net elongation velocity, $v$, is the difference between these two rates:\n$$v = v_{+} - v_{-} = k_{+} m - k_{-}$$\nThis is the required expression for the net elongation velocity as a function of the monomer concentration $m$.\n\nThe problem also defines the critical concentration, $c^{*}$, as the monomer concentration where the net velocity is zero ($v = 0$). At this concentration, the system is at equilibrium.\n$$0 = k_{+} c^{*} - k_{-}$$\nThis definition provides a fundamental relationship between the rate constants and the critical concentration:\n$$c^{*} = \\frac{k_{-}}{k_{+}}$$\nWe can substitute $k_{-} = k_{+} c^{*}$ back into the velocity expression to obtain an alternative, more insightful form:\n$$v = k_{+} m - k_{+} c^{*} = k_{+} (m - c^{*})$$\nThis equation clearly shows that the fibril elongates ($v > 0$) only when the monomer concentration $m$ exceeds the critical concentration $c^{*}$.\n\nNow, we must evaluate the numerical value of the velocity $v$ for the given parameters:\n$k_{+} = 3.2 \\times 10^{5}\\ \\mathrm{M^{-1}\\ s^{-1}}$\n$k_{-} = 0.80\\ \\mathrm{s^{-1}}$\n$m = 7.5\\ \\mu\\mathrm{M}$\n\nFirst, for dimensional consistency, we must convert the monomer concentration from micromolar ($\\mu\\mathrm{M}$) to molar ($\\mathrm{M}$):\n$$m = 7.5\\ \\mu\\mathrm{M} = 7.5 \\times 10^{-6}\\ \\mathrm{M}$$\nWe substitute the numerical values into the first derived expression for velocity, $v = k_{+} m - k_{-}$:\n$$v = (3.2 \\times 10^{5}\\ \\mathrm{M^{-1}\\ s^{-1}}) \\times (7.5 \\times 10^{-6}\\ \\mathrm{M}) - 0.80\\ \\mathrm{s^{-1}}$$\nFirst, calculate the association rate term, $k_{+} m$:\n$$k_{+} m = (3.2 \\times 7.5) \\times (10^{5} \\times 10^{-6})\\ \\mathrm{s^{-1}} = 24 \\times 10^{-1}\\ \\mathrm{s^{-1}} = 2.4\\ \\mathrm{s^{-1}}$$\nNext, compute the net velocity by subtracting the dissociation rate:\n$$v = 2.4\\ \\mathrm{s^{-1}} - 0.80\\ \\mathrm{s^{-1}} = 1.6\\ \\mathrm{s^{-1}}$$\nThe problem statement strictly requires that the final answer be rounded to three significant figures. Adhering to this explicit instruction, the calculated value of $1.6\\ \\mathrm{s^{-1}}$ is presented as $1.60\\ \\mathrm{s^{-1}}$.", "answer": "$$\\boxed{1.60}$$", "id": "2591843"}, {"introduction": "Connecting kinetic models to real-world experiments is a cornerstone of biophysical chemistry. This problem challenges you to act as a data scientist, analyzing hypothetical data from two key spectroscopic techniques used to monitor aggregation: Circular Dichroism (CD) and Thioflavin T (ThT) fluorescence. You will deconvolve the CD signal to track the change in secondary structure and correlate it with the ThT signal for fibril mass, revealing the strong link between $\\beta$-sheet formation and amyloid growth [@problem_id:2591897].", "problem": "A monomeric protein undergoes misfolding and aggregation in aqueous buffer at constant temperature, monitored simultaneously by Circular Dichroism (CD) and Thioflavin T (ThT). The CD report is the Mean Residue Ellipticity (MRE), which, under the usual additivity assumption for far-ultraviolet CD, is a linear combination of canonical basis spectra weighted by fractional secondary structure. Specifically, at each wavelength, the observed MRE is the sum of the helix, sheet, and coil basis MRE values weighted by the fractions of helix, sheet, and coil, respectively. Assume that the fractions are nonnegative and sum to $1$. Thioflavin T (ThT) fluorescence is proportional to the amyloid fibril mass concentration.\n\nYou record CD MRE at three wavelengths, $\\lambda = 208\\,\\mathrm{nm}$, $\\lambda = 218\\,\\mathrm{nm}$, and $\\lambda = 222\\,\\mathrm{nm}$, at $5$ time points $t = 0, 1, 2, 3, 4$ hours during the aggregation reaction. The canonical basis MRE values for $100\\%$ helix, $100\\%$ sheet, and $100\\%$ coil at these wavelengths are, in units of $10^{3}\\ \\mathrm{deg\\ cm^{2}\\ dmol^{-1}}$:\n- At $\\lambda = 208\\,\\mathrm{nm}$: helix $-30$, sheet $-10$, coil $0$.\n- At $\\lambda = 218\\,\\mathrm{nm}$: helix $0$, sheet $-20$, coil $-5$.\n- At $\\lambda = 222\\,\\mathrm{nm}$: helix $-30$, sheet $0$, coil $-5$.\n\nAt each time $t$, the observed CD MRE values (in the same units) are:\n- $t = 0$: $\\mathrm{MRE}_{208} = -19$, $\\mathrm{MRE}_{218} = -3.5$, $\\mathrm{MRE}_{222} = -19.5$.\n- $t = 1$: $\\mathrm{MRE}_{208} = -17$, $\\mathrm{MRE}_{218} = -5.5$, $\\mathrm{MRE}_{222} = -16.5$.\n- $t = 2$: $\\mathrm{MRE}_{208} = -12.5$, $\\mathrm{MRE}_{218} = -8.75$, $\\mathrm{MRE}_{222} = -10.75$.\n- $t = 3$: $\\mathrm{MRE}_{208} = -10.0$, $\\mathrm{MRE}_{218} = -12.5$, $\\mathrm{MRE}_{222} = -6.0$.\n- $t = 4$: $\\mathrm{MRE}_{208} = -10.0$, $\\mathrm{MRE}_{218} = -15.0$, $\\mathrm{MRE}_{222} = -4.0$.\n\nSimultaneously measured Thioflavin T (ThT) fluorescence (arbitrary units, normalized to the monomer baseline at $0$ and the late-time plateau near $1$) at the same times is:\n- $t = 0$: $0.05$,\n- $t = 1$: $0.18$,\n- $t = 2$: $0.42$,\n- $t = 3$: $0.78$,\n- $t = 4$: $0.96$.\n\nUsing the linear additivity of CD MRE and the given basis spectra, compute the sheet fraction at each time point. Then compute the Pearson correlation coefficient between the sheet fraction time series and the ThT fluorescence time series. Express the final result as a unitless decimal and round your answer to four significant figures.", "solution": "The problem is subjected to validation and is found to be scientifically sound, objective, and well-posed. The data provided are consistent and allow for a unique solution.\n\nThe problem requires us to first determine the fraction of $\\beta$-sheet secondary structure, denoted as $f_S$, at each time point from the given Circular Dichroism (CD) data. The observed Mean Residue Ellipticity ($\\text{MRE}$) at a given wavelength $\\lambda$ is a linear combination of the MREs of the basis secondary structures (helix, sheet, coil), weighted by their respective fractions ($f_H, f_S, f_C$).\nThis relationship is described by the equation:\n$$ \\text{MRE}_{\\lambda}^{\\text{obs}} = f_H \\cdot \\text{MRE}_{\\lambda, H} + f_S \\cdot \\text{MRE}_{\\lambda, S} + f_C \\cdot \\text{MRE}_{\\lambda, C} $$\nThe fractions must also satisfy the constraint:\n$$ f_H + f_S + f_C = 1 $$\nWe are given MRE data at three wavelengths: $\\lambda = 208\\,\\mathrm{nm}$, $\\lambda = 218\\,\\mathrm{nm}$, and $\\lambda = 222\\,\\mathrm{nm}$. Using the provided basis MRE values (in units of $10^3\\ \\mathrm{deg\\ cm^2\\ dmol^{-1}}$), we can establish a system of linear equations for each time point:\n$$ -30 f_H - 10 f_S + 0 f_C = \\text{MRE}_{208}^{\\text{obs}} \\quad (1)$$\n$$ 0 f_H - 20 f_S - 5 f_C = \\text{MRE}_{218}^{\\text{obs}} \\quad (2)$$\n$$ -30 f_H + 0 f_S - 5 f_C = \\text{MRE}_{222}^{\\text{obs}} \\quad (3)$$\nWe can use the constraint $f_C = 1 - f_H - f_S$ to reduce the system to two variables, $f_H$ and $f_S$.\nEquation ($1$) is already independent of $f_C$:\n$$ -30 f_H - 10 f_S = \\text{MRE}_{208}^{\\text{obs}} \\quad (1')$$\nSubstituting $f_C$ into equation ($2$):\n$$ -20 f_S - 5 (1 - f_H - f_S) = \\text{MRE}_{218}^{\\text{obs}} $$\n$$ 5 f_H - 15 f_S = \\text{MRE}_{218}^{\\text{obs}} + 5 \\quad (2')$$\nFrom equation ($1'$), we can express $f_H$ in terms of $f_S$:\n$$ f_H = \\frac{-\\text{MRE}_{208}^{\\text{obs}} - 10 f_S}{30} $$\nSubstituting this expression for $f_H$ into equation ($2'$):\n$$ 5 \\left( \\frac{-\\text{MRE}_{208}^{\\text{obs}} - 10 f_S}{30} \\right) - 15 f_S = \\text{MRE}_{218}^{\\text{obs}} + 5 $$\n$$ \\frac{-\\text{MRE}_{208}^{\\text{obs}} - 10 f_S}{6} - 15 f_S = \\text{MRE}_{218}^{\\text{obs}} + 5 $$\nTo solve for $f_S$, we multiply the entire equation by $6$:\n$$ -\\text{MRE}_{208}^{\\text{obs}} - 10 f_S - 90 f_S = 6 (\\text{MRE}_{218}^{\\text{obs}} + 5) $$\n$$ -100 f_S = \\text{MRE}_{208}^{\\text{obs}} + 6 \\cdot \\text{MRE}_{218}^{\\text{obs}} + 30 $$\n$$ f_S = -\\frac{\\text{MRE}_{208}^{\\text{obs}} + 6 \\cdot \\text{MRE}_{218}^{\\text{obs}} + 30}{100} $$\nWe apply this formula to calculate $f_S$ for each time point:\nAt $t=0$: $f_S(0) = -\\frac{(-19) + 6(-3.5) + 30}{100} = -\\frac{-19 - 21 + 30}{100} = -\\frac{-10}{100} = 0.10$.\nAt $t=1$: $f_S(1) = -\\frac{(-17) + 6(-5.5) + 30}{100} = -\\frac{-17 - 33 + 30}{100} = -\\frac{-20}{100} = 0.20$.\nAt $t=2$: $f_S(2) = -\\frac{(-12.5) + 6(-8.75) + 30}{100} = -\\frac{-12.5 - 52.5 + 30}{100} = -\\frac{-35}{100} = 0.35$.\nAt $t=3$: $f_S(3) = -\\frac{(-10.0) + 6(-12.5) + 30}{100} = -\\frac{-10.0 - 75 + 30}{100} = -\\frac{-55}{100} = 0.55$.\nAt $t=4$: $f_S(4) = -\\frac{(-10.0) + 6(-15.0) + 30}{100} = -\\frac{-10.0 - 90 + 30}{100} = -\\frac{-70}{100} = 0.70$.\n\nWe now have two time series of $n=5$ data points each:\nSheet fraction $X = \\{x_i\\}_{i=1}^5 = \\{0.10, 0.20, 0.35, 0.55, 0.70\\}$.\nThT fluorescence $Y = \\{y_i\\}_{i=1}^5 = \\{0.05, 0.18, 0.42, 0.78, 0.96\\}$.\n\nWe compute the Pearson correlation coefficient $r$:\n$$ r = \\frac{\\sum_{i=1}^{n} (x_i - \\bar{x})(y_i - \\bar{y})}{\\sqrt{\\sum_{i=1}^{n} (x_i - \\bar{x})^2} \\sqrt{\\sum_{i=1}^{n} (y_i - \\bar{y})^2}} $$\nFirst, we calculate the mean of each series:\n$$ \\bar{x} = \\frac{1}{5}(0.10 + 0.20 + 0.35 + 0.55 + 0.70) = \\frac{1.90}{5} = 0.38 $$\n$$ \\bar{y} = \\frac{1}{5}(0.05 + 0.18 + 0.42 + 0.78 + 0.96) = \\frac{2.39}{5} = 0.478 $$\nNext, we calculate the sum of the products of deviations (covariance term):\n$$ \\sum_{i=1}^{5} (x_i - \\bar{x})(y_i - \\bar{y}) = (0.10 - 0.38)(0.05 - 0.478) + (0.20 - 0.38)(0.18 - 0.478) + \\dots + (0.70 - 0.38)(0.96 - 0.478) $$\n$$ \\sum = (-0.28)(-0.428) + (-0.18)(-0.298) + (-0.03)(-0.058) + (0.17)(0.302) + (0.32)(0.482) $$\n$$ \\sum = 0.11984 + 0.05364 + 0.00174 + 0.05134 + 0.15424 = 0.3808 $$\nNext, we calculate the sum of squared deviations for each series:\n$$ \\sum_{i=1}^{5} (x_i - \\bar{x})^2 = (-0.28)^2 + (-0.18)^2 + (-0.03)^2 + (0.17)^2 + (0.32)^2 $$\n$$ \\sum = 0.0784 + 0.0324 + 0.0009 + 0.0289 + 0.1024 = 0.243 $$\n$$ \\sum_{i=1}^{5} (y_i - \\bar{y})^2 = (-0.428)^2 + (-0.298)^2 + (-0.058)^2 + (0.302)^2 + (0.482)^2 $$\n$$ \\sum = 0.183184 + 0.088804 + 0.003364 + 0.091204 + 0.232324 = 0.59888 $$\nFinally, we calculate the correlation coefficient $r$:\n$$ r = \\frac{0.3808}{\\sqrt{0.243 \\times 0.59888}} = \\frac{0.3808}{\\sqrt{0.14552784}} \\approx \\frac{0.3808}{0.3814811} \\approx 0.998214... $$\nRounding to four significant figures, the result is $0.9982$. This high positive correlation is scientifically expected, as ThT fluorescence tracks the formation of $\\beta$-sheet rich amyloid fibrils.", "answer": "$$\\boxed{0.9982}$$", "id": "2591897"}, {"introduction": "Why do some proteins aggregate while others remain soluble, and how can a single mutation trigger disease? This exercise delves into the thermodynamic underpinnings of protein stability and its profound effect on aggregation kinetics. Using principles of solvation free energy and Classical Nucleation Theory, you will predict how a single amino acid substitution alters monomer solubility and, consequently, dramatically changes the primary nucleation rate, the crucial first step in forming an aggregate [@problem_id:2591862].", "problem": "A single-site mutation in an amyloid-forming aggregation core replaces a leucine (L) with a lysine (K). Assume that the monomer in dilute aqueous solution at pH $7.0$ is predominantly disordered but partially collapses such that only a fraction $f = 0.20$ of the side chain’s solvent-accessible area effectively contributes to the standard-state solvation free energy of the monomer relevant for its solubility. Use the following experimentally determined side-chain analog transfer free energies from $n$-octanol to water at $298\\ \\text{K}$ as proxies for the solvation free energy contribution per side chain in water: $\\Delta G_{\\text{tr}}(\\text{L}) = +1.5\\ \\text{kcal mol}^{-1}$ and $\\Delta G_{\\text{tr}}(\\text{K}^{+}) = -3.5\\ \\text{kcal mol}^{-1}$. Treat the aggregated state’s per-residue chemical potential as unchanged by the mutation.\n\nLet the wild-type solubility (critical concentration) be $c^{*}_{\\text{wt}} = 2.0\\ \\mu\\text{M}$ at $T = 298\\ \\text{K}$, and consider a fixed total monomer concentration $c_{\\text{tot}} = 100\\ \\mu\\text{M}$. Take the classical nucleation theory (CNT) barrier for primary nucleation to be $\\Delta G^{\\ddagger} = A / (\\ln s)^{2}$ with $s = c_{\\text{tot}}/c^{*}$ the supersaturation and $A = 200\\ \\text{kcal mol}^{-1}$ a system-specific constant. The nucleation rate is $J = J_{0}\\,\\exp(-\\Delta G^{\\ddagger}/k_{B}T)$ with the same prefactor $J_{0}$ for both variants. Use $k_{B}T = 0.593\\ \\text{kcal mol}^{-1}$ at $298\\ \\text{K}$.\n\nStarting from the equality of chemical potentials at solubility and the above CNT expression, compute:\n1. The mutation-induced change in monomer standard-state solvation free energy, $\\Delta\\Delta G_{\\text{solv}}$ (mutant minus wild type), in $\\text{kcal mol}^{-1}$, using the exposure fraction $f$.\n2. The mutant solubility $c^{*}_{\\text{mut}}$ in $\\mu\\text{M}$.\n3. The fold-change in nucleation rate $J_{\\text{mut}}/J_{\\text{wt}}$.\n\nReport as your final answer only the fold-change $J_{\\text{mut}}/J_{\\text{wt}}$ as a dimensionless number rounded to three significant figures.", "solution": "The problem is validated as scientifically grounded, well-posed, and objective. It is based on established principles of physical biochemistry, including chemical potential, solubility, and classical nucleation theory. All data provided are sufficient, consistent, and physically plausible. I will proceed with the solution.\n\nThe problem requires a three-step calculation to determine the fold-change in nucleation rate, $J_{\\text{mut}}/J_{\\text{wt}}$, due to a single-site mutation. The steps are to first calculate the change in monomer solvation free energy, then the resulting change in solubility, and finally the impact on the nucleation rate.\n\nStep 1: Calculate the mutation-induced change in monomer standard-state solvation free energy, $\\Delta\\Delta G_{\\text{solv}}$.\n\nThe problem posits that the effective contribution of a side chain to the standard-state solvation free energy of the monomer, $\\Delta G_{\\text{solv}}$, is a fraction $f$ of its corresponding transfer free energy from a nonpolar solvent ($n$-octanol) to water, $\\Delta G_{\\text{tr}}$.\nThe exposure fraction is given as $f = 0.20$. The transfer free energies for the wild-type Leucine ($L$) and mutant Lysine ($K$) side-chain analogs are $\\Delta G_{\\text{tr}}(\\text{L}) = +1.5\\ \\text{kcal mol}^{-1}$ and $\\Delta G_{\\text{tr}}(\\text{K}^{+}) = -3.5\\ \\text{kcal mol}^{-1}$. At pH $7.0$, the lysine side chain is indeed positively charged.\n\nThe solvation free energy for the wild-type monomer is:\n$$ \\Delta G_{\\text{solv, wt}} = f \\cdot \\Delta G_{\\text{tr}}(\\text{L}) $$\nThe solvation free energy for the mutant monomer is:\n$$ \\Delta G_{\\text{solv, mut}} = f \\cdot \\Delta G_{\\text{tr}}(\\text{K}^{+}) $$\nThe change in the standard-state solvation free energy, $\\Delta\\Delta G_{\\text{solv}}$, is defined as the difference between the mutant and the wild-type values:\n$$ \\Delta\\Delta G_{\\text{solv}} = \\Delta G_{\\text{solv, mut}} - \\Delta G_{\\text{solv, wt}} = f \\left( \\Delta G_{\\text{tr}}(\\text{K}^{+}) - \\Delta G_{\\text{tr}}(\\text{L}) \\right) $$\nSubstituting the given values:\n$$ \\Delta\\Delta G_{\\text{solv}} = 0.20 \\times \\left( (-3.5\\ \\text{kcal mol}^{-1}) - (1.5\\ \\text{kcal mol}^{-1}) \\right) = 0.20 \\times (-5.0\\ \\text{kcal mol}^{-1}) = -1.0\\ \\text{kcal mol}^{-1} $$\nThe mutation stabilizes the monomer in aqueous solution by $1.0\\ \\text{kcal mol}^{-1}$ relative to the wild-type.\n\nStep 2: Calculate the mutant solubility, $c^{*}_{\\text{mut}}$.\n\nSolubility, or the critical concentration $c^{*}$, is the concentration at which monomers in solution are in thermodynamic equilibrium with the aggregated state. At this point, their chemical potentials are equal: $\\mu_{\\text{sol}} = \\mu_{\\text{agg}}$.\nThe chemical potential of the monomer in solution is given by:\n$$ \\mu_{\\text{sol}} = \\mu_{\\text{sol}}^{\\circ} + k_{B}T \\ln(c^{*}) $$\nwhere $\\mu_{\\text{sol}}^{\\circ}$ is the standard-state chemical potential and $k_{B}T$ is the thermal energy. The standard potential can be separated into a solvation contribution and a reference contribution (for the polypeptide backbone and non-solvation effects): $\\mu_{\\text{sol}}^{\\circ} = \\mu_{\\text{ref}}^{\\circ} + \\Delta G_{\\text{solv}}$. The problem states that the chemical potential per monomer in the aggregate, $\\mu_{\\text{agg}}$, is unaffected by the mutation. We also assume $\\mu_{\\text{ref}}^{\\circ}$ is unaffected.\n\nThe equilibrium condition is thus:\n$$ \\mu_{\\text{ref}}^{\\circ} + \\Delta G_{\\text{solv}} + k_{B}T \\ln(c^{*}) = \\mu_{\\text{agg}} $$\nRearranging for $\\ln(c^{*})$ yields:\n$$ k_{B}T \\ln(c^{*}) = (\\mu_{\\text{agg}} - \\mu_{\\text{ref}}^{\\circ}) - \\Delta G_{\\text{solv}} $$\nWe can write this relationship for both the wild-type (wt) and the mutant (mut):\n$$ k_{B}T \\ln(c^{*}_{\\text{wt}}) = (\\mu_{\\text{agg}} - \\mu_{\\text{ref}}^{\\circ}) - \\Delta G_{\\text{solv, wt}} $$\n$$ k_{B}T \\ln(c^{*}_{\\text{mut}}) = (\\mu_{\\text{agg}} - \\mu_{\\text{ref}}^{\\circ}) - \\Delta G_{\\text{solv, mut}} $$\nSubtracting the first equation from the second eliminates the constant term $(\\mu_{\\text{agg}} - \\mu_{\\text{ref}}^{\\circ})$:\n$$ k_{B}T \\left( \\ln(c^{*}_{\\text{mut}}) - \\ln(c^{*}_{\\text{wt}}) \\right) = -\\left( \\Delta G_{\\text{solv, mut}} - \\Delta G_{\\text{solv, wt}} \\right) $$\n$$ k_{B}T \\ln\\left(\\frac{c^{*}_{\\text{mut}}}{c^{*}_{\\text{wt}}}\\right) = -\\Delta\\Delta G_{\\text{solv}} $$\nThis equation directly relates the change in solubility to the change in solvation free energy. Solving for $c^{*}_{\\text{mut}}$:\n$$ c^{*}_{\\text{mut}} = c^{*}_{\\text{wt}} \\exp\\left( -\\frac{\\Delta\\Delta G_{\\text{solv}}}{k_{B}T} \\right) $$\nUsing the given values $c^{*}_{\\text{wt}} = 2.0\\ \\mu\\text{M}$, $\\Delta\\Delta G_{\\text{solv}} = -1.0\\ \\text{kcal mol}^{-1}$, and $k_{B}T = 0.593\\ \\text{kcal mol}^{-1}$:\n$$ c^{*}_{\\text{mut}} = (2.0\\ \\mu\\text{M}) \\exp\\left( -\\frac{-1.0\\ \\text{kcal mol}^{-1}}{0.593\\ \\text{kcal mol}^{-1}} \\right) = (2.0\\ \\mu\\text{M}) \\exp\\left(\\frac{1.0}{0.593}\\right) $$\nThe increased stability of the mutant monomer in solution leads to a higher solubility.\n\nStep 3: Calculate the fold-change in nucleation rate, $J_{\\text{mut}}/J_{\\text{wt}}$.\n\nThe nucleation rate, $J$, is given by the Arrhenius-like expression from classical nucleation theory (CNT):\n$$ J = J_{0} \\exp\\left(-\\frac{\\Delta G^{\\ddagger}}{k_{B}T}\\right) $$\nThe nucleation energy barrier is $\\Delta G^{\\ddagger} = A / (\\ln s)^{2}$, where $A$ is a constant and $s = c_{\\text{tot}}/c^{*}$ is the supersaturation. The total monomer concentration is fixed at $c_{\\text{tot}} = 100\\ \\mu\\text{M}$. Since the prefactor $J_{0}$ is assumed to be the same for both variants, the ratio of rates is:\n$$ \\frac{J_{\\text{mut}}}{J_{\\text{wt}}} = \\frac{J_{0} \\exp\\left(-\\Delta G^{\\ddagger}_{\\text{mut}} / k_{B}T\\right)}{J_{0} \\exp\\left(-\\Delta G^{\\ddagger}_{\\text{wt}} / k_{B}T\\right)} = \\exp\\left( \\frac{\\Delta G^{\\ddagger}_{\\text{wt}} - \\Delta G^{\\ddagger}_{\\text{mut}}}{k_{B}T} \\right) $$\nSubstituting the expression for $\\Delta G^{\\ddagger}$:\n$$ \\frac{J_{\\text{mut}}}{J_{\\text{wt}}} = \\exp\\left\\{ \\frac{A}{k_{B}T} \\left[ \\frac{1}{(\\ln s_{\\text{wt}})^{2}} - \\frac{1}{(\\ln s_{\\text{mut}})^{2}} \\right] \\right\\} $$\nWe now calculate the supersaturations. For the wild-type:\n$$ s_{\\text{wt}} = \\frac{c_{\\text{tot}}}{c^{*}_{\\text{wt}}} = \\frac{100\\ \\mu\\text{M}}{2.0\\ \\mu\\text{M}} = 50 $$\nFor the mutant, we use the relationship between the solubilities:\n$$ s_{\\text{mut}} = \\frac{c_{\\text{tot}}}{c^{*}_{\\text{mut}}} = \\frac{c_{\\text{tot}}}{c^{*}_{\\text{wt}} \\exp\\left( -\\frac{\\Delta\\Delta G_{\\text{solv}}}{k_{B}T} \\right)} = s_{\\text{wt}} \\exp\\left( \\frac{\\Delta\\Delta G_{\\text{solv}}}{k_{B}T} \\right) $$\nThe natural logarithm of the mutant supersaturation is:\n$$ \\ln(s_{\\text{mut}}) = \\ln(s_{\\text{wt}}) + \\frac{\\Delta\\Delta G_{\\text{solv}}}{k_{B}T} $$\nWe can now compute the values for the exponent in the rate ratio expression:\n$$ \\frac{A}{k_{B}T} = \\frac{200\\ \\text{kcal mol}^{-1}}{0.593\\ \\text{kcal mol}^{-1}} \\approx 337.2681 $$\n$$ \\ln(s_{\\text{wt}}) = \\ln(50) \\approx 3.912023 $$\n$$ \\frac{\\Delta\\Delta G_{\\text{solv}}}{k_{B}T} = \\frac{-1.0\\ \\text{kcal mol}^{-1}}{0.593\\ \\text{kcal mol}^{-1}} \\approx -1.686341 $$\n$$ \\ln(s_{\\text{mut}}) \\approx 3.912023 - 1.686341 = 2.225682 $$\nNow we insert these into the exponent of the rate ratio:\n$$ \\text{Exponent} = \\frac{A}{k_{B}T} \\left[ \\frac{1}{(\\ln s_{\\text{wt}})^{2}} - \\frac{1}{(\\ln s_{\\text{mut}})^{2}} \\right] \\approx 337.2681 \\times \\left[ \\frac{1}{(3.912023)^{2}} - \\frac{1}{(2.225682)^{2}} \\right] $$\n$$ \\text{Exponent} \\approx 337.2681 \\times \\left[ \\frac{1}{15.3039} - \\frac{1}{4.95368} \\right] \\approx 337.2681 \\times (0.065342 - 0.201870) $$\n$$ \\text{Exponent} \\approx 337.2681 \\times (-0.136528) \\approx -46.0463 $$\nFinally, the fold-change in nucleation rate is:\n$$ \\frac{J_{\\text{mut}}}{J_{\\text{wt}}} = \\exp(-46.0463) \\approx 9.948 \\times 10^{-21} $$\nRounding to three significant figures, the result is $9.95 \\times 10^{-21}$. The mutation dramatically increases monomer solubility, which lowers the supersaturation and thus raises the nucleation barrier, causing a drastic reduction in the nucleation rate.", "answer": "$$\\boxed{9.95 \\times 10^{-21}}$$", "id": "2591862"}]}